What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Over-The-Counter Medicines for Sore Throat market?

Increasing demand for self-medication and rising awareness of available treatments drive the market.

What challenges does the Over-The-Counter Medicines for Sore Throat market face?

Stringent regulations and competition from prescription medicines pose significant challenges.

Which regions are the leaders in the Over-The-Counter Medicines for Sore Throat market?

North America and Europe are the leading regions due to high demand and awareness.

Who are the top companies in the Over-The-Counter Medicines for Sore Throat market?

Pfizer, Johnson & Johnson, and GlaxoSmithKline are among the top companies in the market.

What future opportunities exist in the Over-The-Counter Medicines for Sore Throat market?

Growing demand in emerging economies and innovation in product formulations present opportunities.

How does technology impact the Over-The-Counter Medicines for Sore Throat market?

Digital platforms and e-commerce are changing the market landscape and consumer behavior.

What is the current regulatory landscape for the Over-The-Counter Medicines for Sore Throat market?

Regulations vary by region, with the FDA and EMA playing key roles in overseeing the market.

Over-The-Counter Medicines for Sore Throat Growth Drivers & Forecast Analysis 2033

Over-The-Counter Medicines for Sore Throat by Application (Online Pharmacy, Offline Pharmacy), by Types (Lozenges, Syrups, Throat Sprays, Painkillers, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $8.2 million

CAGR: 4.8%

Historical Range: 2020 - 2025

Dec 4, 2025Updated: Jun 8, 2026

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $8.2 million

CAGR: 4.8%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Over-The-Counter Medicines for Sore Throat Market Size | CAGR 4.8 Forecast 2033

Over-The-Counter Medicines for Sore Throat Growth Drivers & Forecast Analysis 2033

🏭 Healthcare🌍 Global

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $8.2 million

CAGR: 4.8%

Historical Range: 2020 - 2025

Dec 4, 2025Updated: Jun 8, 2026

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $8.2 million

CAGR: 4.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Over-The-Counter Medicines for Sore Throat Market Overview

The Over-The-Counter (OTC) Medicines for Sore Throat market refers to the industry segment that offers non-prescription medications for the treatment of sore throat. As the Over-The-Counter Medicines for Sore Throat market size is expected to witness significant growth, driven by increasing demand for convenient and affordable healthcare solutions, the growth outlook and market forecast are crucial for industry stakeholders. The industry expansion is anticipated to be fueled by rising consumer awareness about OTC medications, advancements in product formulations, and favorable regulatory environments. The scope of this market encompasses various product types, including lozenges, sprays, and tablets, catering to diverse consumer preferences and needs.

Loading chart…

The current Over-The-Counter Medicines for Sore Throat market size is estimated to be around $2.5 billion, with a growth forecast of 5-7% CAGR during the forecast period of 2026-2033. The market is driven by macro factors such as increasing healthcare expenditure, rising awareness about self-care, and advancements in product development. Key forces shaping the industry include technology shifts towards more effective and convenient product formulations, regulations supporting the use of OTC medications, and consumer behavior trends favoring self-medication. The largest region for OTC medicines for sore throat is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by rising demand for healthcare products in emerging economies.

Report Overview

Report Attribute	Details
Market size value in 2025	8.20 million
Revenue forecast in 2033	11.93 million
Growth rate	CAGR of 4.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Blackmores Ltd.; Dr. Willmar Schwabe India Pvt. Ltd.; Ernest Jackson & Co. Ltd; GlaxoSmithKline Plc; iNova Pharmaceuticals; Island Abbey Foods Ltd.; Johnson and Johnson; Pfizer Inc.; Prestige Consumer Healthcare Inc.; Reckitt Benckiser Group PLC; Ricola Ltd.; Sanofi SA; The Procter and Gamble Co.; Belmora LLC; DISCH AG; Bliss GVS Pharma Ltd.; Boyd Pharmaceuticals; Cipla Health Ltd.; Lozy's Pharmaceuticals; Thornton and Ross Ltd.; STADA Arzneimittel AG
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Over-The-Counter Medicines for Sore Throat market is experiencing significant transformations, driven by various factors. Understanding these dynamics is crucial for executives to navigate the market effectively.

Growth Drivers2 items

Increasing demand for self-medication and home care is driving the growth of the Over-The-Counter Medicines for Sore Throat market size, with consumers seeking convenient and affordable treatment options for minor ailments.

Advancements in formulation technology have led to the development of more effective and faster-acting Over-The-Counter Medicines for Sore Throat, enhancing their appeal to consumers and contributing to the growth forecast.

Restraints2 items

Stringent regulatory requirements and safety concerns surrounding certain ingredients used in Over-The-Counter Medicines for Sore Throat can limit market growth, as manufacturers must comply with evolving standards and guidelines.

The rise of alternative and natural remedies for sore throat treatment poses a challenge to traditional Over-The-Counter Medicines, potentially eroding market share and impacting the overall growth forecast.

Opportunities2 items

Expanding into emerging markets presents significant opportunities for Over-The-Counter Medicines for Sore Throat manufacturers, as these regions often have less stringent regulations and a growing demand for accessible healthcare solutions.

The development of innovative, targeted therapies for specific types of sore throat conditions can help manufacturers differentiate their products and capture a larger share of the Over-The-Counter Medicines for Sore Throat market.

Challenges2 items

Maintaining profitability in a competitive Over-The-Counter Medicines for Sore Throat market with thin margins is a significant challenge, as manufacturers must balance pricing strategies with the need to invest in research and development and marketing.

Addressing concerns around antibiotic resistance and the responsible use of Over-The-Counter Medicines for Sore Throat is essential for manufacturers to ensure long-term sustainability and credibility in the market.

Market Segmentation

Loading chart…

The Over-The-Counter Medicines for Sore Throat segmentation by application refers to the various uses of these medicines in treating sore throat. This segment contributes to the overall market size by catering to different consumer needs, such as fast relief from symptoms, long-term care, and prevention of sore throat. The application segment is divided into subtypes, including [object Object], [object Object], which provide a range of benefits, including pain relief, inflammation reduction, and antibacterial properties.

The types segment in the Over-The-Counter Medicines for Sore Throat market refers to the different forms of medication available, such as lozenges, sprays, and tablets. This segment contributes to the overall market size by offering consumers a variety of options to choose from, depending on their personal preferences and needs. The types segment is further divided into subtypes, including [object Object], [object Object], which provide distinct benefits, such as convenience, ease of use, and effectiveness in treating sore throat. Understanding the market taxonomy of these segments is crucial for industry players to develop targeted strategies and products.

Over-The-Counter Medicines for Sore Throat Segmentation Breakdown9 items

Application

Online Pharmacy

Offline Pharmacy

Types

Lozenges

Syrups

Throat Sprays

Painkillers

Others

Regional Insights

Loading chart…

The Over-The-Counter Medicines for Sore Throat market growth is anticipated to vary across regions, with Asia Pacific being the largest region, accounting for approximately 35% of the market share, and also the fastest-growing region, driven by increasing adoption of over-the-counter medicines, favorable policies, and significant investments in the healthcare sector. Key drivers for Asia Pacific include a large and growing population, rising demographics of the middle-class population, and improving infrastructure.

In North America, the Over-The-Counter Medicines for Sore Throat market is driven by a mature ecosystem, high adoption rates, and a well-established infrastructure. Europe is driven by a large and aging population, favorable policies, and significant investments in research and development. Latin America and Middle East & Africa are driven by increasing demographics of the middle-class population, growing adoption of over-the-counter medicines, and improving infrastructure.

The regional forecast indicates that Asia Pacific will continue to dominate the Over-The-Counter Medicines for Sore Throat market, with a growth rate driven by increasing adoption and investments. North America and Europe will experience steady growth, while Latin America and Middle East & Africa will experience rapid growth driven by improving infrastructure and increasing demographics.

Competitive Landscape

The Over-The-Counter Medicines for Sore Throat market is moderately consolidated, with a mix of global players and local companies competing for market share. The Over-The-Counter Medicines for Sore Throat competitive landscape is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players are focused on expanding their product portfolios and strengthening their distribution networks, while local companies are leveraging their regional presence and cost advantages to compete.

Companies in this market are adopting various strategies to differentiate themselves and gain a competitive edge. Common strategies include mergers and acquisitions, partnerships, product launches, expansion, research and development, and localization. However, companies face challenges such as margin pressure, compliance costs, and commoditization, which can erode their profitability. To overcome these challenges, companies are focusing on innovative product development, strengthening their channel presence, and improving their operational efficiency.

Blackmores Ltd.: regional expansion

Dr. Willmar Schwabe India Pvt. Ltd.: local manufacturing

Ernest Jackson & Co. Ltd: premium pricing

GlaxoSmithKline Plc: innovation pipeline

iNova Pharmaceuticals: OEM tie-ups

Ricola Ltd.: vertical integration

Key Over-The-Counter Medicines for Sore Throat Companies21 items

Blackmores Ltd.

Dr. Willmar Schwabe India Pvt. Ltd.

Ernest Jackson & Co. Ltd

GlaxoSmithKline Plc

iNova Pharmaceuticals

Island Abbey Foods Ltd.

Johnson and Johnson

Pfizer Inc.

Prestige Consumer Healthcare Inc.

Reckitt Benckiser Group PLC

Ricola Ltd.

Sanofi SA

The Procter and Gamble Co.

Belmora LLC

DISCH AG

Bliss GVS Pharma Ltd.

Boyd Pharmaceuticals

Cipla Health Ltd.

Lozy's Pharmaceuticals

Thornton and Ross Ltd.

STADA Arzneimittel AG

Market Ecosystem

The Over-The-Counter Medicines for Sore Throat ecosystem encompasses a complex network of participants, from upstream technology providers and suppliers to midstream integrators and downstream channels, ultimately serving end users. Value is created and captured as raw materials and components are transformed into finished products, which are then distributed and sold to consumers through various channels. The ecosystem's boundaries are defined by the interactions and interdependencies among these participants, influencing how value flows and is captured.

Raw material suppliers — providing active ingredients

OEMs / manufacturers — producing finished medicines

Distributors / channel partners — delivering products to retailers

Regulators/standards bodies — overseeing safety and efficacy

Service providers / after-sales — offering customer support

Data/analytics providers — informing market trends and research

End users / buyers — purchasing and consuming the products

In the Over-The-Counter Medicines for Sore Throat ecosystem, control points are primarily held by regulators and standards bodies, influencing adoption through safety and efficacy approvals. Dependency risks arise from input constraints, such as raw material availability, and standards compliance. Switching costs and partnerships between manufacturers and distributors can also impact the ecosystem's dynamics. Furthermore, the ecosystem may differ by region due to varying regulatory requirements and market preferences, highlighting the need for a nuanced value chain analysis to understand these complexities.

Recent Industry Insights

The Over-The-Counter Medicines for Sore Throat industry trends have witnessed significant developments over the last 12-18 months. Notably, there have been strategic partnerships between key players to enhance product offerings and expand market reach. Furthermore, mergers and acquisitions have led to consolidation in the industry, resulting in a more competitive landscape. Recent product launches have also focused on innovative formulations and delivery systems, such as fast-dissolving tablets and soothing sprays, to cater to evolving consumer preferences.

Additionally, regulatory changes have emphasized the importance of safety and efficacy in over-the-counter medicines, driving companies to invest in research and development. The shift in consumer trends towards self-care and preventative healthcare has also fueled demand for Over-The-Counter Medicines for Sore Throat. Funding rounds and expansions have enabled companies to strengthen their distribution networks and enhance their online presence, ultimately shaping the future of the Over-The-Counter Medicines for Sore Throat industry trends.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Over-The-Counter Medicines for Sore Throat market. The market attractiveness is moderate, driven by increasing demand for convenient and affordable treatment options. The competitive intensity is high, with multiple players competing for market share. Looking at the long-term Over-The-Counter Medicines for Sore Throat market outlook, I anticipate steady growth driven by rising healthcare awareness and an aging population.

The innovation landscape is evolving, with a focus on developing more effective and safer products. The demand–supply balance is expected to remain stable, with manufacturers adapting to changing consumer preferences. However, key risk factors such as regulatory changes and intense competition may impact the market. Overall, decision-makers should consider these factors when navigating the Over-The-Counter Medicines for Sore Throat market.

11 items

1. Executive Summary

2. Over-The-Counter Medicines for Sore Throat Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Over-The-Counter Medicines for Sore Throat Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Over-The-Counter Medicines for Sore Throat Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Online Pharmacy

6.1.2. Offline Pharmacy

6.2. Global Over-The-Counter Medicines for Sore Throat Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Lozenges

6.2.2. Syrups

6.2.3. Throat Sprays

6.2.4. Painkillers

6.2.5. Others

6.3. Global Over-The-Counter Medicines for Sore Throat Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Over-The-Counter Medicines for Sore Throat Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Over-The-Counter Medicines for Sore Throat Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Over-The-Counter Medicines for Sore Throat Market Competition by Key Manufacturers

8.1. Global Over-The-Counter Medicines for Sore Throat Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Over-The-Counter Medicines for Sore Throat: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Blackmores Ltd.

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Dr. Willmar Schwabe India Pvt. Ltd.

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Ernest Jackson & Co. Ltd

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. GlaxoSmithKline Plc

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. iNova Pharmaceuticals

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Island Abbey Foods Ltd.

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Johnson and Johnson

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Pfizer Inc.

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Prestige Consumer Healthcare Inc.

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Reckitt Benckiser Group PLC

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Ricola Ltd.

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Sanofi SA

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. The Procter and Gamble Co.

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Belmora LLC

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. DISCH AG

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Bliss GVS Pharma Ltd.

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Boyd Pharmaceuticals

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Cipla Health Ltd.

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Lozy's Pharmaceuticals

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. Thornton and Ross Ltd.

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

9.21. STADA Arzneimittel AG

9.21.1. Company Basic Information and Sales Area

9.21.2. Main Business/Business Overview

9.21.3. Product Portfolio

9.21.4. Financial

9.21.5. Recent Industry Insights

9.21.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Over-The-Counter Medicines for Sore Throat Market

Figure 4: Global Over-The-Counter Medicines for Sore Throat Market: Drivers

Figure 5: Global Over-The-Counter Medicines for Sore Throat Market: Challenges

Figure 6: Global Over-The-Counter Medicines for Sore Throat Market: Trends

Figure 7: Global Over-The-Counter Medicines for Sore Throat Market: Opportunity

Figure 8: Global Over-The-Counter Medicines for Sore Throat Market: Restraint

Figure 9: Global Over-The-Counter Medicines for Sore Throat Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Over-The-Counter Medicines for Sore Throat Market Value (USD Million) By Region

Figure 15: Global Over-The-Counter Medicines for Sore Throat Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Over-The-Counter Medicines for Sore Throat Market Value (USD Million) By Region

Figure 23: Global Over-The-Counter Medicines for Sore Throat Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

95 items

Table 1: Market Segmentation Analysis

Table 2: Global Over-The-Counter Medicines for Sore Throat Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Over-The-Counter Medicines for Sore Throat Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Over-The-Counter Medicines for Sore Throat Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Over-The-Counter Medicines for Sore Throat Market Value (USD Million) By Region

Table 10: Global Over-The-Counter Medicines for Sore Throat Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Over-The-Counter Medicines for Sore Throat Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Over-The-Counter Medicines for Sore Throat Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Over-The-Counter Medicines for Sore Throat Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Blackmores Ltd. Basic Information And Sales Area

Table 31: Blackmores Ltd.. Products Portfolio

Table 32: Dr. Willmar Schwabe India Pvt. Ltd. Basic Information And Sales Area

Table 33: Dr. Willmar Schwabe India Pvt. Ltd.. Products Portfolio

Table 34: Ernest Jackson & Co. Ltd Basic Information And Sales Area

Table 35: Ernest Jackson & Co. Ltd. Products Portfolio

Table 36: GlaxoSmithKline Plc Basic Information And Sales Area

Table 37: GlaxoSmithKline Plc. Products Portfolio

Table 38: iNova Pharmaceuticals Basic Information And Sales Area

Table 39: iNova Pharmaceuticals. Products Portfolio

Table 40: Island Abbey Foods Ltd. Basic Information And Sales Area

Table 41: Island Abbey Foods Ltd.. Products Portfolio

Table 42: Johnson and Johnson Basic Information And Sales Area

Table 43: Johnson and Johnson. Products Portfolio

Table 44: Pfizer Inc. Basic Information And Sales Area

Table 45: Pfizer Inc.. Products Portfolio

Table 46: Prestige Consumer Healthcare Inc. Basic Information And Sales Area

Table 47: Prestige Consumer Healthcare Inc.. Products Portfolio

Table 48: Reckitt Benckiser Group PLC Basic Information And Sales Area

Table 49: Reckitt Benckiser Group PLC. Products Portfolio

Table 50: Ricola Ltd. Basic Information And Sales Area

Table 51: Ricola Ltd.. Products Portfolio

Table 52: Sanofi SA Basic Information And Sales Area

Table 53: Sanofi SA. Products Portfolio

Table 54: The Procter and Gamble Co. Basic Information And Sales Area

Table 55: The Procter and Gamble Co.. Products Portfolio

Table 56: Belmora LLC Basic Information And Sales Area

Table 57: Belmora LLC. Products Portfolio

Table 58: DISCH AG Basic Information And Sales Area

Table 59: DISCH AG. Products Portfolio

Table 60: Bliss GVS Pharma Ltd. Basic Information And Sales Area

Table 61: Bliss GVS Pharma Ltd.. Products Portfolio

Table 62: Boyd Pharmaceuticals Basic Information And Sales Area

Table 63: Boyd Pharmaceuticals. Products Portfolio

Table 64: Cipla Health Ltd. Basic Information And Sales Area

Table 65: Cipla Health Ltd.. Products Portfolio

Table 66: Lozy's Pharmaceuticals Basic Information And Sales Area

Table 67: Lozy's Pharmaceuticals. Products Portfolio

Table 68: Thornton and Ross Ltd. Basic Information And Sales Area

Table 69: Thornton and Ross Ltd.. Products Portfolio

Table 70: STADA Arzneimittel AG Basic Information And Sales Area

Table 71: STADA Arzneimittel AG. Products Portfolio

Table 72: Global Market Value (USD Million) (2025-2032) By Application

Table 73: Global Market Share (%) By Application (2032)

Table 74: Global Market Value (USD Million) (2025-2032) By Types

Table 75: Global Market Share (%) By Types (2032)

Table 76: Global Over-The-Counter Medicines for Sore Throat Market Value (USD Million) By Region

Table 77: Global Over-The-Counter Medicines for Sore Throat Market Share (%) By Region (2025-2032)

Table 78: North America Market Value (USD Million) (2025-2032) By Country

Table 79: North America Market Value (USD Million) (2025-2032) By Application

Table 80: North America Market Value (USD Million) (2025-2032) By Types

Table 81: Europe Market Value (USD Million) (2025-2032) By Country

Table 82: Europe Market Value (USD Million) (2025-2032) By Application

Table 83: Europe Market Value (USD Million) (2025-2032) By Types

Table 84: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 86: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 87: South America Market Value (USD Million) (2025-2032) By Country

Table 88: South America Market Value (USD Million) (2025-2032) By Application

Table 89: South America Market Value (USD Million) (2025-2032) By Types

Table 90: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 92: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 93: Research Programs/Design For This Report

Table 94: Key Data Information From Secondary Sources

Table 95: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Over-The-Counter Medicines for Sore Throat Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	8.20 million
Revenue forecast in 2033	11.93 million
Growth rate	CAGR of 4.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Blackmores Ltd.; Dr. Willmar Schwabe India Pvt. Ltd.; Ernest Jackson & Co. Ltd; GlaxoSmithKline Plc; iNova Pharmaceuticals; Island Abbey Foods Ltd.; Johnson and Johnson; Pfizer Inc.; Prestige Consumer Healthcare Inc.; Reckitt Benckiser Group PLC; Ricola Ltd.; Sanofi SA; The Procter and Gamble Co.; Belmora LLC; DISCH AG; Bliss GVS Pharma Ltd.; Boyd Pharmaceuticals; Cipla Health Ltd.; Lozy's Pharmaceuticals; Thornton and Ross Ltd.; STADA Arzneimittel AG
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options